[1] Li B, Liu H, Shang HW, et al. Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients. Afr Health Sci, 2013, 13:703-709.
[2] 李婷.miR-646高表达抑制EGFR/Akt通路及肺癌细胞增殖扩散的研究.标记免疫分析与临床,2017,24:322-325.
[3] 李勇,龚泰芳,孙景东, 等.微小RNA-494介导人成纤维细胞生长因子受体2调控骨肉瘤细胞侵袭和迁移的机制.中华实验外科杂志,2018,35:2010-2013.
[4] Chen Y, Shen Z, Zhi Y, et al. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression. Arch Biochem Biophys, 2018, 645:117-125.
[5] He RQ, Yang X, Liang L, et al. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study. Oncol Lett, 2018, 15:5517-5532.
[6] Liu X, Zhang A, Xiang J, et al. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Oncol Rep, 2016, 36:1385-1392.
[7] Guo X, Lv X, Lv X, et al. Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis. Oncotarget, 2017, 8:44050-44058.
[8] Oishi N, Kumar MR, Roessler S, et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology, 2012, 56:1792-1803.
[9] Li Y, Bai W, Zhang J. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1. Biomed Pharmacother, 2017, 92:1038-1044. |
